AEPCX | CIVAX | AEPCX / CIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 5 years | - |
Gain YTD | 5.488 | 4.299 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 131B | 2.04B | 6,425% |
Annual Yield % from dividends | 0.81 | 1.10 | 74% |
Returns for 1 year | 7.63 | 6.39 | 119% |
Returns for 3 years | -6.82 | 3.54 | -193% |
Returns for 5 years | 4.81 | 22.63 | 21% |
Returns for 10 years | 21.95 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSAQX | 22.37 | 0.13 | +0.58% |
Morgan Stanley Inst Asia Opp I | |||
MSEQX | 61.68 | 0.23 | +0.37% |
Morgan Stanley Inst Growth I | |||
WOOQX | 19.14 | -0.19 | -0.98% |
JPMorgan SMID Cap Equity R4 | |||
EEMGX | 8.09 | -0.09 | -1.10% |
MFS Emerging Markets Equity Research R4 | |||
NINLX | 22.30 | -0.31 | -1.37% |
Neuberger Berman Intrinsic Value I |